111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts
Immunohistochemical epidermal growth factor receptor (EGFR) expression does not correlate with treatment response in head and neck squamous cell carcinomas (HNSCC). Aim was to apply the tracer 111In-cetuximab-F(ab’)2 for EGFR microSPECT imaging and to investigate if tracer uptake correlated with res...
Ausführliche Beschreibung
Autor*in: |
van Dijk, Laura K. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2013 |
---|
Schlagwörter: |
---|
Umfang: |
5 |
---|
Übergeordnetes Werk: |
Enthalten in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells - Han, Xiaobing ELSEVIER, 2021, journal of the European Society for Therapeutic Radiology and Oncology, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:108 ; year:2013 ; number:3 ; pages:484-488 ; extent:5 |
Links: |
---|
DOI / URN: |
10.1016/j.radonc.2013.06.034 |
---|
Katalog-ID: |
ELV011388587 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV011388587 | ||
003 | DE-627 | ||
005 | 20230623091127.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180602s2013 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.radonc.2013.06.034 |2 doi | |
028 | 5 | 2 | |a GBVA2013004000001.pica |
035 | |a (DE-627)ELV011388587 | ||
035 | |a (ELSEVIER)S0167-8140(13)00313-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 570 |a 540 |q VZ |
100 | 1 | |a van Dijk, Laura K. |e verfasserin |4 aut | |
245 | 1 | 0 | |a 111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts |
264 | 1 | |c 2013 | |
300 | |a 5 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Immunohistochemical epidermal growth factor receptor (EGFR) expression does not correlate with treatment response in head and neck squamous cell carcinomas (HNSCC). Aim was to apply the tracer 111In-cetuximab-F(ab’)2 for EGFR microSPECT imaging and to investigate if tracer uptake correlated with response to EGFR-inhibition by cetuximab in HNSCC xenografts. Usage of F(ab)2 fragments allows for shorter interval between tracer injection and imaging. | ||
650 | 7 | |a Head and neck cancer |2 Elsevier | |
650 | 7 | |a Preclinical |2 Elsevier | |
650 | 7 | |a Cetuximab |2 Elsevier | |
650 | 7 | |a EGFR imaging |2 Elsevier | |
650 | 7 | |a SPECT |2 Elsevier | |
700 | 1 | |a Hoeben, Bianca A.W. |4 oth | |
700 | 1 | |a Stegeman, Hanneke |4 oth | |
700 | 1 | |a Kaanders, Johannes H.A.M. |4 oth | |
700 | 1 | |a Franssen, Gerben M. |4 oth | |
700 | 1 | |a Boerman, Otto C. |4 oth | |
700 | 1 | |a Bussink, Johan |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Han, Xiaobing ELSEVIER |t Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |d 2021 |d journal of the European Society for Therapeutic Radiology and Oncology |g Amsterdam [u.a.] |w (DE-627)ELV00004122X |
773 | 1 | 8 | |g volume:108 |g year:2013 |g number:3 |g pages:484-488 |g extent:5 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.radonc.2013.06.034 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 108 |j 2013 |e 3 |h 484-488 |g 5 | ||
953 | |2 045F |a 610 |
author_variant |
d l k v dlk dlkv |
---|---|
matchkey_str |
vandijklaurakhoebenbiancaawstegemanhanne:2013----:1ictxmba2pciaigoqatfctooacsileiemlrwhatr |
hierarchy_sort_str |
2013 |
publishDate |
2013 |
allfields |
10.1016/j.radonc.2013.06.034 doi GBVA2013004000001.pica (DE-627)ELV011388587 (ELSEVIER)S0167-8140(13)00313-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ van Dijk, Laura K. verfasserin aut 111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Immunohistochemical epidermal growth factor receptor (EGFR) expression does not correlate with treatment response in head and neck squamous cell carcinomas (HNSCC). Aim was to apply the tracer 111In-cetuximab-F(ab’)2 for EGFR microSPECT imaging and to investigate if tracer uptake correlated with response to EGFR-inhibition by cetuximab in HNSCC xenografts. Usage of F(ab)2 fragments allows for shorter interval between tracer injection and imaging. Head and neck cancer Elsevier Preclinical Elsevier Cetuximab Elsevier EGFR imaging Elsevier SPECT Elsevier Hoeben, Bianca A.W. oth Stegeman, Hanneke oth Kaanders, Johannes H.A.M. oth Franssen, Gerben M. oth Boerman, Otto C. oth Bussink, Johan oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:108 year:2013 number:3 pages:484-488 extent:5 https://doi.org/10.1016/j.radonc.2013.06.034 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 108 2013 3 484-488 5 045F 610 |
spelling |
10.1016/j.radonc.2013.06.034 doi GBVA2013004000001.pica (DE-627)ELV011388587 (ELSEVIER)S0167-8140(13)00313-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ van Dijk, Laura K. verfasserin aut 111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Immunohistochemical epidermal growth factor receptor (EGFR) expression does not correlate with treatment response in head and neck squamous cell carcinomas (HNSCC). Aim was to apply the tracer 111In-cetuximab-F(ab’)2 for EGFR microSPECT imaging and to investigate if tracer uptake correlated with response to EGFR-inhibition by cetuximab in HNSCC xenografts. Usage of F(ab)2 fragments allows for shorter interval between tracer injection and imaging. Head and neck cancer Elsevier Preclinical Elsevier Cetuximab Elsevier EGFR imaging Elsevier SPECT Elsevier Hoeben, Bianca A.W. oth Stegeman, Hanneke oth Kaanders, Johannes H.A.M. oth Franssen, Gerben M. oth Boerman, Otto C. oth Bussink, Johan oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:108 year:2013 number:3 pages:484-488 extent:5 https://doi.org/10.1016/j.radonc.2013.06.034 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 108 2013 3 484-488 5 045F 610 |
allfields_unstemmed |
10.1016/j.radonc.2013.06.034 doi GBVA2013004000001.pica (DE-627)ELV011388587 (ELSEVIER)S0167-8140(13)00313-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ van Dijk, Laura K. verfasserin aut 111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Immunohistochemical epidermal growth factor receptor (EGFR) expression does not correlate with treatment response in head and neck squamous cell carcinomas (HNSCC). Aim was to apply the tracer 111In-cetuximab-F(ab’)2 for EGFR microSPECT imaging and to investigate if tracer uptake correlated with response to EGFR-inhibition by cetuximab in HNSCC xenografts. Usage of F(ab)2 fragments allows for shorter interval between tracer injection and imaging. Head and neck cancer Elsevier Preclinical Elsevier Cetuximab Elsevier EGFR imaging Elsevier SPECT Elsevier Hoeben, Bianca A.W. oth Stegeman, Hanneke oth Kaanders, Johannes H.A.M. oth Franssen, Gerben M. oth Boerman, Otto C. oth Bussink, Johan oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:108 year:2013 number:3 pages:484-488 extent:5 https://doi.org/10.1016/j.radonc.2013.06.034 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 108 2013 3 484-488 5 045F 610 |
allfieldsGer |
10.1016/j.radonc.2013.06.034 doi GBVA2013004000001.pica (DE-627)ELV011388587 (ELSEVIER)S0167-8140(13)00313-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ van Dijk, Laura K. verfasserin aut 111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Immunohistochemical epidermal growth factor receptor (EGFR) expression does not correlate with treatment response in head and neck squamous cell carcinomas (HNSCC). Aim was to apply the tracer 111In-cetuximab-F(ab’)2 for EGFR microSPECT imaging and to investigate if tracer uptake correlated with response to EGFR-inhibition by cetuximab in HNSCC xenografts. Usage of F(ab)2 fragments allows for shorter interval between tracer injection and imaging. Head and neck cancer Elsevier Preclinical Elsevier Cetuximab Elsevier EGFR imaging Elsevier SPECT Elsevier Hoeben, Bianca A.W. oth Stegeman, Hanneke oth Kaanders, Johannes H.A.M. oth Franssen, Gerben M. oth Boerman, Otto C. oth Bussink, Johan oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:108 year:2013 number:3 pages:484-488 extent:5 https://doi.org/10.1016/j.radonc.2013.06.034 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 108 2013 3 484-488 5 045F 610 |
allfieldsSound |
10.1016/j.radonc.2013.06.034 doi GBVA2013004000001.pica (DE-627)ELV011388587 (ELSEVIER)S0167-8140(13)00313-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 540 VZ van Dijk, Laura K. verfasserin aut 111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Immunohistochemical epidermal growth factor receptor (EGFR) expression does not correlate with treatment response in head and neck squamous cell carcinomas (HNSCC). Aim was to apply the tracer 111In-cetuximab-F(ab’)2 for EGFR microSPECT imaging and to investigate if tracer uptake correlated with response to EGFR-inhibition by cetuximab in HNSCC xenografts. Usage of F(ab)2 fragments allows for shorter interval between tracer injection and imaging. Head and neck cancer Elsevier Preclinical Elsevier Cetuximab Elsevier EGFR imaging Elsevier SPECT Elsevier Hoeben, Bianca A.W. oth Stegeman, Hanneke oth Kaanders, Johannes H.A.M. oth Franssen, Gerben M. oth Boerman, Otto C. oth Bussink, Johan oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:108 year:2013 number:3 pages:484-488 extent:5 https://doi.org/10.1016/j.radonc.2013.06.034 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 108 2013 3 484-488 5 045F 610 |
language |
English |
source |
Enthalten in Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells Amsterdam [u.a.] volume:108 year:2013 number:3 pages:484-488 extent:5 |
sourceStr |
Enthalten in Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells Amsterdam [u.a.] volume:108 year:2013 number:3 pages:484-488 extent:5 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Head and neck cancer Preclinical Cetuximab EGFR imaging SPECT |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
authorswithroles_txt_mv |
van Dijk, Laura K. @@aut@@ Hoeben, Bianca A.W. @@oth@@ Stegeman, Hanneke @@oth@@ Kaanders, Johannes H.A.M. @@oth@@ Franssen, Gerben M. @@oth@@ Boerman, Otto C. @@oth@@ Bussink, Johan @@oth@@ |
publishDateDaySort_date |
2013-01-01T00:00:00Z |
hierarchy_top_id |
ELV00004122X |
dewey-sort |
3610 |
id |
ELV011388587 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV011388587</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623091127.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.radonc.2013.06.034</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013004000001.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV011388587</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-8140(13)00313-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">van Dijk, Laura K.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Immunohistochemical epidermal growth factor receptor (EGFR) expression does not correlate with treatment response in head and neck squamous cell carcinomas (HNSCC). Aim was to apply the tracer 111In-cetuximab-F(ab’)2 for EGFR microSPECT imaging and to investigate if tracer uptake correlated with response to EGFR-inhibition by cetuximab in HNSCC xenografts. Usage of F(ab)2 fragments allows for shorter interval between tracer injection and imaging.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Head and neck cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Preclinical</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cetuximab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EGFR imaging</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SPECT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hoeben, Bianca A.W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stegeman, Hanneke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kaanders, Johannes H.A.M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Franssen, Gerben M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boerman, Otto C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bussink, Johan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Han, Xiaobing ELSEVIER</subfield><subfield code="t">Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells</subfield><subfield code="d">2021</subfield><subfield code="d">journal of the European Society for Therapeutic Radiology and Oncology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00004122X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:108</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:484-488</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.radonc.2013.06.034</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">108</subfield><subfield code="j">2013</subfield><subfield code="e">3</subfield><subfield code="h">484-488</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
van Dijk, Laura K. |
spellingShingle |
van Dijk, Laura K. ddc 610 ddc 570 Elsevier Head and neck cancer Elsevier Preclinical Elsevier Cetuximab Elsevier EGFR imaging Elsevier SPECT 111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts |
authorStr |
van Dijk, Laura K. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV00004122X |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry & allied sciences |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 570 540 VZ 111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts Head and neck cancer Elsevier Preclinical Elsevier Cetuximab Elsevier EGFR imaging Elsevier SPECT Elsevier |
topic |
ddc 610 ddc 570 Elsevier Head and neck cancer Elsevier Preclinical Elsevier Cetuximab Elsevier EGFR imaging Elsevier SPECT |
topic_unstemmed |
ddc 610 ddc 570 Elsevier Head and neck cancer Elsevier Preclinical Elsevier Cetuximab Elsevier EGFR imaging Elsevier SPECT |
topic_browse |
ddc 610 ddc 570 Elsevier Head and neck cancer Elsevier Preclinical Elsevier Cetuximab Elsevier EGFR imaging Elsevier SPECT |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
b a h ba bah h s hs j h k jh jhk g m f gm gmf o c b oc ocb j b jb |
hierarchy_parent_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
hierarchy_parent_id |
ELV00004122X |
dewey-tens |
610 - Medicine & health 570 - Life sciences; biology 540 - Chemistry |
hierarchy_top_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV00004122X |
title |
111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts |
ctrlnum |
(DE-627)ELV011388587 (ELSEVIER)S0167-8140(13)00313-7 |
title_full |
111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts |
author_sort |
van Dijk, Laura K. |
journal |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
journalStr |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology 500 - Science |
recordtype |
marc |
publishDateSort |
2013 |
contenttype_str_mv |
zzz |
container_start_page |
484 |
author_browse |
van Dijk, Laura K. |
container_volume |
108 |
physical |
5 |
class |
610 610 DE-600 570 540 VZ |
format_se |
Elektronische Aufsätze |
author-letter |
van Dijk, Laura K. |
doi_str_mv |
10.1016/j.radonc.2013.06.034 |
dewey-full |
610 570 540 |
title_sort |
111in-cetuximab-f(ab’)2 spect imaging for quantification of accessible epidermal growth factor receptors (egfr) in hnscc xenografts |
title_auth |
111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts |
abstract |
Immunohistochemical epidermal growth factor receptor (EGFR) expression does not correlate with treatment response in head and neck squamous cell carcinomas (HNSCC). Aim was to apply the tracer 111In-cetuximab-F(ab’)2 for EGFR microSPECT imaging and to investigate if tracer uptake correlated with response to EGFR-inhibition by cetuximab in HNSCC xenografts. Usage of F(ab)2 fragments allows for shorter interval between tracer injection and imaging. |
abstractGer |
Immunohistochemical epidermal growth factor receptor (EGFR) expression does not correlate with treatment response in head and neck squamous cell carcinomas (HNSCC). Aim was to apply the tracer 111In-cetuximab-F(ab’)2 for EGFR microSPECT imaging and to investigate if tracer uptake correlated with response to EGFR-inhibition by cetuximab in HNSCC xenografts. Usage of F(ab)2 fragments allows for shorter interval between tracer injection and imaging. |
abstract_unstemmed |
Immunohistochemical epidermal growth factor receptor (EGFR) expression does not correlate with treatment response in head and neck squamous cell carcinomas (HNSCC). Aim was to apply the tracer 111In-cetuximab-F(ab’)2 for EGFR microSPECT imaging and to investigate if tracer uptake correlated with response to EGFR-inhibition by cetuximab in HNSCC xenografts. Usage of F(ab)2 fragments allows for shorter interval between tracer injection and imaging. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
container_issue |
3 |
title_short |
111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts |
url |
https://doi.org/10.1016/j.radonc.2013.06.034 |
remote_bool |
true |
author2 |
Hoeben, Bianca A.W. Stegeman, Hanneke Kaanders, Johannes H.A.M. Franssen, Gerben M. Boerman, Otto C. Bussink, Johan |
author2Str |
Hoeben, Bianca A.W. Stegeman, Hanneke Kaanders, Johannes H.A.M. Franssen, Gerben M. Boerman, Otto C. Bussink, Johan |
ppnlink |
ELV00004122X |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth |
doi_str |
10.1016/j.radonc.2013.06.034 |
up_date |
2024-07-06T19:56:05.727Z |
_version_ |
1803860852842954752 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV011388587</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623091127.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.radonc.2013.06.034</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013004000001.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV011388587</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-8140(13)00313-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">van Dijk, Laura K.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">111In-cetuximab-F(ab’)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Immunohistochemical epidermal growth factor receptor (EGFR) expression does not correlate with treatment response in head and neck squamous cell carcinomas (HNSCC). Aim was to apply the tracer 111In-cetuximab-F(ab’)2 for EGFR microSPECT imaging and to investigate if tracer uptake correlated with response to EGFR-inhibition by cetuximab in HNSCC xenografts. Usage of F(ab)2 fragments allows for shorter interval between tracer injection and imaging.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Head and neck cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Preclinical</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cetuximab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EGFR imaging</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SPECT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hoeben, Bianca A.W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stegeman, Hanneke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kaanders, Johannes H.A.M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Franssen, Gerben M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boerman, Otto C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bussink, Johan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Han, Xiaobing ELSEVIER</subfield><subfield code="t">Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells</subfield><subfield code="d">2021</subfield><subfield code="d">journal of the European Society for Therapeutic Radiology and Oncology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00004122X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:108</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:484-488</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.radonc.2013.06.034</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">108</subfield><subfield code="j">2013</subfield><subfield code="e">3</subfield><subfield code="h">484-488</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.400502 |